BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
목요일, 9월 24

BeOne Medicines Ltd

ONCNASDAQ
Trade with Public
Trade with Public
$365.00
-3.08-0.84%
가까이에: Sep 23, 5:00 PM EST
$362.88
-2.12-0.58%
시간외: 9:30 AM EST
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

BeOne Medicines Market Sentiment

Market sentiment signals for BeOne Medicines (ONC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy
Short Interest▼ 1.8% short float
Options Flow— N/A
Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

20 analysts

Options Flow (P/C)

—

0 calls · 4 puts

Avg Consensus PT

$386

+6.3%

Highest Price Target

$454

+25.1%

TD Cowen

Lowest Price Target

$311

-14.3%

RBC Capital

Short Interest

1.8%

Rising — Bearish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Sep 10, 2026Barclays
Etzer Darout—
+14.4%$407 → $415MaintainedOverweight
Aug 6, 2026TD Cowen
Yaron Werber—
+25.1%$424 → $454MaintainedBuy
More with Benzinga EdgeGet Access

Insider & Market Activity News

Aaron Rosenberg Implements A Sell Strategy: Offloads $361K In BeOne Medicines Stock

It was reported on August 5, that Aaron Rosenberg, Chief Financial Officer at BeOne Medicines (NASDAQ:ONC) executed a significant insider sell, according to an SEC filing. What Happened: After conducting a thorough
Benzinga Insights

Insider Selling: Chan Henry Lee Unloads $337K Of BeOne Medicines Stock

On August 3, a recent SEC filing unveiled that Chan Henry Lee, SVP at BeOne Medicines (NASDAQ:ONC) made an insider sell. What Happened: Lee's recent move involves selling 1,044 shares of BeOne Medicines. This
Benzinga Insights

Lai Wang Executes Sell Order: Offloads $295K In BeOne Medicines Stock

It was reported on June 25, that Lai Wang, President at BeOne Medicines (NASDAQ:ONC) executed a significant insider sell, according to an SEC filing. What Happened: According to a Form 4 filing with the U.S. Securities
Benzinga Insights

Chief Executive Officer At BeOne Medicines Sells $933K Of Stock

Disclosed on June 25, JOHN OYLER, Chief Executive Officer at BeOne Medicines (NASDAQ:ONC), executed a substantial insider sell as per the latest SEC filing. What Happened: OYLER's decision to sell 3,410 shares of
Benzinga Insights

President and COO At BeOne Medicines Sells $356K Of Stock

Xiaobin Wu, President and COO at BeOne Medicines (NASDAQ:ONC), reported an insider sell on June 25, according to a new SEC filing. What Happened: Wu opted to sell 1,292 shares of BeOne Medicines, according to a Form 4
Benzinga Insights

Lai Wang Executes Sell Order: Offloads $310K In BeOne Medicines Stock

Revealing a significant insider sell on June 18, Lai Wang, President at BeOne Medicines (NASDAQ:ONC), as per the latest SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on
Benzinga Insights

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved